The 10 most recently reported publications
Diese Arbeit beschäftigt sich mit der Entwicklung eines, für die kontrollierte Freisetzung hydrophiler Wirkstoffe geeigneten, Verkapselungssystems mit dem Ziel die Freisetzung osteospezifischer P2-Liganden zu verzögern, um bei der Behandlung von Knochendefekten kritischer Größe die Bildung neuen Knochengewebes zu gewährleisten. Hierfür werden, unter Anwendung der immersiven Layer-by-Layer-Beschichtung, mit den Modell-Substanzen Adenosintriphosphat und Suramin versetzte, Alginat sowie κ-Carrageen-Kapseln mit Chitosan und Lignosulfonat beschichtet und auf ihr Freisetzungsverhalten hin untersucht.
The Symposium on Virtual and Augmented Reality (SVR) is the premier conference on Virtual and Augmented Reality in Brazil. Traditionally sponsored by the Brazilian Computer Society (SBC), SVR is in its 21th edition and has established itself as an international scientific forum for the exchange of experience and knowledge among researchers, professionals, practitioners, students and developers concerned with research and development of human-computer interfaces focused on Virtual, Augmented and Mixed Realities.
The special section in Computers & Graphics Journal (CAG) is an alternative track for paper submission. All accepted papers are scheduled for oral presentation at SVR. The paper presentation instructions and the no show policy are the same as those of full papers accepted in the main conference track; please, see the website for full instructions.
Gefährdet die Nutzung von Gesundheits-Apps und Wearables die solidarische Krankenversicherung?
(2019)
Blutdruck messen, Schrittzahl verfolgen, Schlaf kontrollieren, Zuckerwerte im Blick haben und sogar die Durchführung von EKGs – dies sind nur einige der Anwendungen, die ein gängiges Mobiltelefon oder eine Smartwatch mit entsprechender Software durchführen können. Apps und Wearables (so werden am Körper getragene Computertechnologien genannt) werden in ihren Einsatzmöglichkeiten immer vielfältiger.
Im Rahmen der Arbeit wurde Kraft-Lignin mit Natriumsulfit demethyliert, um den Gehalt an aromatischen Hydroxygruppen zu erhöhen und damit die Reaktivität des Lignins in Bezug auf Polyurethan-Synthesen zu erhöhen. Variiert wurden die Demethylierungstemperatur (72°C, 90°C) sowie der pH-Wert zur Isolierung des Kraft-Lignins (pH 2, 3, 4 und 5). Die Analyse der demethylierten Proben erfolgte mittels differentieller UV-Spektroskopie und der OH-Gehaltbestimmung via automatischer Titration (angelehnt an ISO 14900:2001(E)). Weitere Untersuchungen umfassten Löslichkeitstests sowie Strukturanalysen via FTIR- und UV/Vis-Spektroskopie.
2-methylacetoacetyl-coenzyme A thiolase (beta-ketothiolase) deficiency: one disease - two pathways
(2019)
Background: 2-methylacetoacetyl-coenzyme A thiolase deficiency (MATD; deficiency of mitochondrial acetoacetyl-coenzyme A thiolase T2/ “beta-ketothiolase”) is an autosomal recessive disorder of ketone body utilization and isoleucine degradation due to mutations in ACAT1.
Methods: We performed a systematic literature search for all available clinical descriptions of patients with MATD. 244 patients were identified and included in this analysis. Clinical course and biochemical data are presented and discussed.
Results: For 89.6 % of patients at least one acute metabolic decompensation was reported. Age at first symptoms ranged from 2 days to 8 years (median 12 months). More than 82% of patients presented in the first two years of life, while manifestation in the neonatal period was the exception (3.4%). 77.0% (157 of 204 patients) of patients showed normal psychomotor development without neurologic abnormalities.
Conclusion: This comprehensive data analysis provides a systematic overview on all cases with MATD identified in the literature. It demonstrates that MATD is a rather benign disorder with often favourable outcome, when compared with many other organic acidurias.
Background 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency (HMGCLD) is an autosomal recessive disorder of ketogenesis and leucine degradation due to mutations in HMGCL .
Method We performed a systematic literature search to identify all published cases. 211 patients of whom relevant clinical data were available were included in this analysis. Clinical course, biochemical findings and mutation data are highlighted and discussed. An overview on all published HMGCL variants is provided.
Results More than 95% of patients presented with acute metabolic decompensation. Most patients manifested within the first year of life, 42.4% already neonatally. Very few individuals remained asymptomatic. The neurologic long-term outcome was favorable with 62.6% of patients showing normal development.
Conclusion This comprehensive data analysis provides a systematic overview on all published cases with HMGCLD including a list of all known HMGCL mutations.
Pozzolanic properties of Pennisetum purpureum grass ash were tested on Portland cement. Results show that the ash can be blended with cements without compromising binding strength of the cement. It was found that Portland cement could be blended with Pennisetum purpureum up to a ratio of 3:2 compromising compressive strength of mortar.Mortar with lower cement replacement took longer to set as evidenced by lower compressive strength within the 28-day aging time. Mortar with higher cement replacement had lower water absorption capacity, an indication that the test pozzolan was of smaller particulate size. XRF analysis and the FTIR spectrum showed that the ash has a higher content of silica. The XRD pattern of the ash showed that the ash was predominantly amorphous. SEM images showed that the ash produced at 600 o C had residual carbon material.
Mesenchymal Stem Cells
(2020)
This chapter focuses on mesenchymal stem cells (MSCs), a multipotent stem cell type that has been found in a variety of tissues and organs of the human body since their discovery in 1970. Their main function is to maintain and repair the respective tissue in vivo. Mesenchymal stem cells can be easily isolated from different tissues and can undergo extensive self-proliferation prior to differentiation into various mesodermal cell types such as osteoblasts, chondrocytes, adipocytes, tenocytes, myocytes, and fibroblasts. Because of this vast differentiation potential, mesenchymal stem cells are a promising tool for regenerative medicine approaches. They could play an important role in cellular therapy, tissue replacement and regeneration in the future. Mesenchymal stem cells will be compared for their application and differentiation potential to embryonic stem cells and induced pluripotent stem cells and the limitations and challenges using scaffolds for tissue repair will be presented. In addition, legal and ethical aspects of the use of mesenchymal stem cells will be discussed. Moreover, isolation protocols for mesenchymal stem cells from the most common sources namely bone marrow, adipose tissue and umbilical cord are included.
